Darlene Deptulahicks - SVP & Chief Financial Officer, T2 Biosystems, Inc

As of June 8, 2017


Darlene Deptulahicks Net Worth

  • Net worth is estimated to be at least $1.8M
  • Owns at least 4,000 units of T2 Biosystems, Inc stock

Darlene Deptulahicks Trading

  • Largest purchase of shares was 4,000 units , worth over $14.32K on June 8, 2017
  • In total has made about 2 transactions over a month
  • Usually trades in May and June, with the busiest year in 2017
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Darlene Deptulahicks Mailing Address

  • Mailing address is C/o Icad, Inc. 98 Spit Brook Road, Suite 100 Nashua NH 03062 NH

T2 Biosystems, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
John Sperzel, 2020 $490,705 - - $2,571,384 $393,750 $3,000 $3,458,839
John McDonough, 2020 $72,906 - $74,999 - - $1,022,182 $1,170,087
John McDonough, 2019 $550,000 - $372,000 $478,728 $233,750 $3,000 $1,637,478
Alec Barclay, 2020 $340,000 - $25,675 $38,621 $234,600 $952 $639,848
Alec Barclay, 2019 $337,500 $35,000 $111,600 $348,834 $102,000 $2,900 $937,834
Anthony Pare, 2020 $325,000 - $20,738 $159,763 $185,250 $3,000 $693,751
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1492674/000119312521161531/d23237ddef14a.htm

T2 Biosystems, Inc Insider Trading

  • The most recent transaction was 41,128 units sold on August 3, 2021 by Goldman Sachs Co Llc and Goldman Sachs Group Inc worth over $25.66K
  • In the last 6 years, insiders at T2 Biosystems, Inc sold an estimated value of $8.88M and bought an estimated value of $60.72M
  • The most active traders are Thomas Lowery, Chief Scientific Officer,  David Elsbree, Director,  and John Sprague Attorney-In-Fact, Director
  • Insider trading is most common in June, with the busiest year in 2015

T2 Biosystems, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1